Qing Chai

Qing Chai is currently the Associate Vice President at Eli Lilly & Co, where they continue to lead efforts in biomedicine development aimed at improving patient lives. With over a decade of experience in antibody and protein biotherapeutics, they have specialized in protein biophysics, engineering, and biologic drug design. Qing previously held positions as Principal Research Scientist and Executive Director at Eli Lilly, and completed a postdoctoral fellowship at The Scripps Research Institute. They earned a Doctor of Medicine from Capital University of Medical Sciences and both a Master's and a PhD in biomedicine from Peking Union Medical College and Irell & Manella Graduate School, respectively.